Allergan: Evercore sees split more likely

Allergan (NYSE:AGN) has jumped 3.2%, as Evercore ISI notes the company seems to be headed toward a split of its aesthetics and therapeutics business.

After talking with the company’s general counsel, Evercore’s Umer Raffat reportedly says “I walked away with the sense that Allergan is heading towards a split and may likely lay out timelines … We may get an update in ‘next couple of months.’ ” (h/t Andrew Dunn)

Allergan had announced plans last May to sell its women’s health and infectious disease businesses, before that effort stalled earlier this year.

https://seekingalpha.com/news/3472158-allergan-plus-3_2-percent-evercore-seeing-split-likely